The Genzyme PAL Awards grants program was launched in 2011 to encourage bold new ideas and programs to support the LSD community worldwide. The PAL program funds innovative projects in disease awareness and education, community mobilization, non-profit development and good governance activities, patient care and support programs. Overwhelmingly successful in its first three years, Genzyme looks forward to launching the fourth annual PAL program in 2014.
We encourage all potential applicants to review Past Awards and the Grant Guidelines page to help spark ideas and possibilities.
Proposals are reviewed by an External Review Committee and selected through a blinded selection process. Proposals are reviewed using a set of established criteria. For more information on the review criteria, please see Grant Guidelines.
The Review Committee is comprised of five committee members with expertise in such areas as philanthropy, rare disease advocacy, rare disease research and treatment, communications and non-profit management. The biographies of the External Review Committee members will be made available online.
Genzyme works with patient organizations around the world.
Genzyme Rare Community
Stay up to date on important work in the LSD and rare disease communities.